Company Norda ASA

Stocks

NORD

NO0010285190

Biotechnology & Medical Research

End-of-day quote Norwegian OTC 2026-10-21			5-day change	1st Jan Change
86.00 ^NOK	+1.06%		-.--%	-14.00%

06-16	Norda ASA announces Annual dividend, payable on June 25, 2026	CI
25-05-12	Norda ASA announces Annual dividend, payable on May 22, 2025	CI

Business description: Norda ASA

Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Companyâ€™s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.

Number of employees: 1

Sales by Activity: Norda ASA

Fiscal Period: December	2020 (NOK)	2021 (NOK)	2022 (NOK)	2023 (NOK)	2024 (NOK)
Sample Preparation	469M	139M	128M	86.92M	372M

See all business segments

Executive Committee: Norda ASA

Manager	Title	Age	Since
Frode Westvold CEO	Chief Executive Officer	-	2013-04-07

See NORDA ASA governance

Composition of the Board of Directors: Norda ASA

Director	Title	Age	Since
Christian Åbyholm CHM	Chairman	54	2014-01-30
Hans Johan Hekland BRD	Director/Board Member	68	2013-06-19
Pia Hverven Axell BRD	Director/Board Member	-	-

Composition of the Board of Directors

Holdings: Norda ASA

Name	Stocks	%	Valuation
Morrow Bank AB 1.93%	6,102,908	1.93%	10 M $
NYKODE THERAPEUTICS 4.52%	17,701,755	4.52%	7 M $
GENTIAN DIAGNOSTICS 4.63%	716,099	4.63%	3 M $
ARCTICZYMES TECHNOLOGIES ASA 1.71%	873,935	1.71%	2 M $
ARCTICZYMES TECHNOLOGIES ASA 2.22%	664,067	2.22%	1 M $
Q-LINEA AB 3.16%	598,999	3.16%	1 M $

Company details: Norda ASA

NORDA ASA

Stortingsgaten 28

0161, Oslo

+47 92 42 35 61

http://www.nordasa.no

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NORDA ASA	+1.06%	-.--%	+6.17%	+109.76%	46.73M
WUXI APPTEC CO., LTD.	+2.24%	+5.83%	+58.47%	+65.65%	66.7B
ARGENX SE	+4.66%	+8.90%	+14.57%	+85.41%	56.88B
LONZA GROUP AG	-0.60%	+1.73%	+23.48%	+94.40%	56.53B
BEONE MEDICINES AG	+3.11%	+15.88%	+27.17%	+120.86%	46.49B
IQVIA HOLDINGS INC.	+2.83%	+8.27%	+31.34%	+45.81%	44.8B
REVOLUTION MEDICINES, INC.	+4.37%	+6.68%	+220.01%	+902.71%	41.59B
CELLTRION, INC.	-0.47%	+9.60%	+27.53%	+52.88%	35.35B
GENMAB A/S	+3.80%	-1.00%	+95.20%	+66.79%	33.29B
INSMED INCORPORATED	+0.48%	+4.50%	-40.48%	+387.72%	25.1B
Average	+2.20%	+3.07%	+46.35%	+193.20%	40.68B
Weighted average by Cap.	+2.42%	+3.97%	+51.63%	+180.98%